Jain, A
Patients should be advised to seek prompt medical evaluation for severe or persistent gastrointestinal symptoms, vision changes, unusual neck swelling or hoarseness, or severe constipation with abdominal distention
Prenatal exposure to GLP-1 receptor agonists and other second-line antidiabetics may not pose greater risk to infants than insulin For immediate release: December 11, 2023 Boston, MAInfants born to women with pre-gestational type 2 diabetes who take second-line non-insulin antidiabetic medications (ADMs) during pregnancy are at no higher risk of major congenital malformations (MCMs) than infants born to those who take insulin, according to a new study led by Harvard T.H
Overall Metabolic Support: By addressing multiple facets of lipid metabolism and liver health, the LipoC blend is studied for its potential to support overall metabolic balance and efficiency
In the landmark STEP 1 clinical trial, patients lost an average of 14.9% of body weight over 68 weeks compared to 2.4% with placebo
Mounjaro is approved only for type 2 diabetes